首页> 外文OA文献 >Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein
【2h】

Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein

机译:特异于结核分枝杆菌16-kDa蛋白免疫显性表位的人CD4 + T克隆的细胞因子谱,HLA限制和TCR序列分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The identification of immunodominant and universal mycobacterial peptides could be applied to vaccine design and have an employment as diagnostic reagents. In this paper we have investigated the fine specificity, clonal composition and HLA class II restriction of CD4+ T cell clones specific for an immunodominant epitope spanning amino acids 91–110 of the 16-kDa protein of Mycobacterium tuberculosis. Twenty-one of the tested 28 clones had a Th1 profile, while seven clones had a Th0 profile. None of the clones had a Th2 profile. While the TCR AV gene usage of the clones was heterogeneous, a dominant TCR BV2 gene family was used by 18 of the 28 clones. The CDR3 regions of BV2+ T cell clones showed variation in lengths, but a putative common motif R-L/V-G/S-Y/W-E/D was detected in 13 of the 18 clones. Moreover, the last two to three residues of the putative CDR3 loops, encoded by conserved BJ sequences, could also play a role in peptide recognition. Antibody blockade and fine restriction analysis using HLA-DR homozygous antigen-presenting cells established that 16 of 18 BV2+ peptide-specific clones were DR restricted and two clones were DR-DQ and DR-DP restricted. Additionally, five of the 18 TCRBV2+ clones recognized peptide 91–110 in association with both parental and diverse HLA-DR molecules, indicating their promiscuous recognition pattern. The ability of peptide 91–110 to bind a wide range of HLA-DR molecules, and to stimulate a Th1-type interferon (IFN)-γ response more readily, encourage the use of this peptide as a subunit vaccine component.
机译:免疫显性和通用分枝杆菌肽的鉴定可用于疫苗设计,并可作为诊断试剂使用。在本文中,我们研究了针对结核分枝杆菌16-kDa蛋白第91-110位氨基酸的免疫显性表位特异性的CD4 + T细胞克隆的特异性,克隆组成和HLA II类限制。测试的28个克隆中有21个具有Th1谱,而七个克隆具有Th0谱。没有一个克隆具有Th2谱。尽管这些克隆的TCR AV基因用法是异质的,但28个克隆中的18个使用了显性TCR BV2基因家族。 BV2 + T细胞克隆的CDR3区长度发生变化,但在18个克隆中的13个中检测到了假定的共有基序R-L / V-G / S-Y / W-E / D。而且,由保守的BJ序列编码的假定的CDR3环的最后两至三个残基也可以在肽识别中起作用。使用HLA-DR纯合子抗原呈递细胞进行的抗体阻断和精细限制性分析确定18个BV2 +肽特异性克隆中的16个是DR限制性的,两个克隆是DR-DQ和DR-DP限制性的。此外,18个TCRBV2 +克隆中有5个与亲本和不同的HLA-DR分子结合识别了91-110肽,表明它们的混杂识别模式。肽91–110结合多种HLA-DR分子并更容易刺激Th1型干扰素(IFN)-γ反应的能力,鼓励将该肽用作亚单位疫苗成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号